Novo Nordisk
NVO
#71
Rank
โ‚น20.501 T
Marketcap
โ‚น4,614
Share price
7.30%
Change (1 day)
-37.90%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): โ‚น1.797 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น47.21 Billion. In 2024 the company made an earning of โ‚น1.691 Trillion, an increase over its 2023 earnings that were of โ‚น1.377 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น1.797 T6.23%
2024 โ‚น1.691 T22.84%
2023 โ‚น1.377 T57.81%
2022 โ‚น872.78 B5.24%
2021 โ‚น829.35 B12.38%
2020 โ‚น737.97 B13.11%
2019 โ‚น652.45 B-3.45%
2018 โ‚น675.76 B1.88%
2017 โ‚น663.27 B4.3%
2016 โ‚น635.90 B10.32%
2015 โ‚น576.40 B7.47%
2014 โ‚น536.36 B3.4%
2013 โ‚น518.71 B19.09%
2012 โ‚น435.58 B15.58%
2011 โ‚น376.87 B16.58%
2010 โ‚น323.28 B25.66%
2009 โ‚น257.27 B10.68%
2008 โ‚น232.45 B55.82%
2007 โ‚น149.18 B7.02%
2006 โ‚น139.39 B19.05%
2005 โ‚น117.09 B10.55%
2004 โ‚น105.91 B
2002 โ‚น73.86 B-14.39%
2001 โ‚น86.28 B-52.82%
2000 โ‚น182.86 B250%
1999 โ‚น52.24 B31.21%
1998 โ‚น39.81 B34.31%
1997 โ‚น29.64 B11.46%
1996 โ‚น26.59 B9.03%
1995 โ‚น24.39 B-3.15%
1994 โ‚น25.18 B-0.67%
1993 โ‚น25.35 B45.38%
1992 โ‚น17.44 B-13.81%
1991 โ‚น20.23 B37.12%
1990 โ‚น14.75 B-0.79%
1989 โ‚น14.87 B26.2%
1988 โ‚น11.78 B24.97%
1987 โ‚น9.43 B-0.9%
1986 โ‚น9.51 B-7.78%
1985 โ‚น10.32 B24.87%
1984 โ‚น8.26 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.059 T-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.011 T 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น718.11 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น813.52 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France